Home LiteratureArticle Details
PMID: 8617868 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.

The Journal of clinical investigation ·Vol. 97 ·No. 6 ·1996-03-15 ·Pages 1373-81

Flamand L, Stefanescu I, Menezes J

Abstract

The marked tropism of human herpesvirus-6 (HHV-6) for natural killer (NK) cells and T lymphocytes has led us to investigate the effect of HHV-6 on cellular cytotoxicity. We describe here how HHV-6 infection of peripheral blood mononuclear cells (PBMC) leads to upregulation of their NK cell cytotoxicity. The induction of NK cell activity by HHV-6 was abrogated by monoclonal antibodies (mAbs) to IL-15 but not by mAbs to other cytokines (IFN-alpha, IFN-gamma, TNF-alpha, TNF-beta, IL-2, IL-12) suggesting that IL-15 secreted in response to viral infection was responsible for the observed effect. Furthermore, NK activation by HHV-6 was blocked with mAb to CD122, as well as by human anti-HHV-6 neutralizing antibodies. Using RT-PCR, we were able to detect IL-15 mRNA upregulation in purified monocyte and NK cell preparations. IL-15 protein synthesis was increased in response to HHV-6. Finally, addition of IL-15 to PBMC cultures was found to severely curtail HHV-6 expression. Taken together, our data suggest that enhanced NK activity in response to viral infection represent a natural anti-viral defense mechanism aimed at rapidly eliminating virus-infected cells.

MeSH Terms
Base Sequence Cells, Cultured Cytotoxicity, Immunologic Herpesviridae Infections/immunology,metabolism Herpesvirus 6, Human Humans Interleukin-15 Interleukins/biosynthesis,immunology Killer Cells, Natural/immunology,virology Molecular Sequence Data RNA, Messenger/analysis Up-Regulation
Chemicals
Interleukin-15 Interleukins RNA, Messenger
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Flamand L
Pediatric Research Center, University of Montreal, Quebec, Canada.
Stefanescu I
Menezes J
References (26)
26 references, click to expand
  1. Natural killer cells: their roles in defenses against disease.
    Science. 1981 Oct 2;214(4516):24-30 PMID: 7025208
  2. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation.
    Blood. 1995 Mar 1;85(5):1263-71 PMID: 7858257
  3. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.
    Science. 1986 Oct 31;234(4776):596-601 PMID: 2876520
  4. Genomic analysis of the human B-lymphotropic virus (HBLV).
    Science. 1986 Oct 31;234(4776):601-3 PMID: 3020691
  5. Human B-lymphotropic virus (human herpesvirus-6).
    J Virol Methods. 1988 Sep;21(1-4):29-48 PMID: 2846617
  6. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.
    J Virol. 1989 Feb;63(2):970-3 PMID: 2911127
  7. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.
    Nature. 1989 Jan 26;337(6205):370-3 PMID: 2463490
  8. Severe herpesvirus infections in an adolescent without natural killer cells.
    N Engl J Med. 1989 Jun 29;320(26):1731-5 PMID: 2543925
  9. Biology of natural killer cells.
    Adv Immunol. 1989;47:187-376 PMID: 2683611
  10. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer.
    EMBO J. 1989 Oct;8(10):3019-27 PMID: 2573513
  11. T-cell activation is required for efficient replication of human herpesvirus 6.
    J Virol. 1990 Sep;64(9):4598-602 PMID: 2166835
  12. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6.
    Nature. 1991 Feb 7;349(6309):533-5 PMID: 1846951
  13. Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments.
    J Virol. 1991 Jun;65(6):2895-902 PMID: 1851861
  14. Latent human herpesvirus 6 infection of human monocytes/macrophages.
    J Gen Virol. 1991 Jun;72 ( Pt 6):1401-8 PMID: 1646280
  15. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.
    J Immunol. 1991 Jul 15;147(2):685-91 PMID: 1677024
  16. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.
    J Virol. 1991 Sep;65(9):5105-10 PMID: 1651426
  17. Interferon and natural killer cell activity in patients with exanthem subitum.
    Pediatr Infect Dis J. 1992 May;11(5):369-73 PMID: 1378586
  18. Infection of natural killer cells by human herpesvirus 6.
    Nature. 1993 Apr 1;362(6419):458-62 PMID: 7681936
  19. Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells.
    J Infect Dis. 1993 Jun;167(6):1274-80 PMID: 8388898
  20. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.
    J Exp Med. 1993 Sep 1;178(3):961-9 PMID: 8394407
  21. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    J Virol. 1993 Nov;67(11):6768-77 PMID: 8411380
  22. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.
    Science. 1994 May 13;264(5161):965-8 PMID: 8178155
  23. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4935-9 PMID: 8197160
  24. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4940-4 PMID: 8197161
  25. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
    EMBO J. 1994 Jun 15;13(12):2822-30 PMID: 8026467
  26. A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections.
    J Pediatr. 1982 May;100(5):727-30 PMID: 6279813
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1996-03-15
Pages
1373-81
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC507195
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com